{"name":"Woo-Keun Seo","slug":"woo-keun-seo","ticker":"","exchange":"","domain":"","description":"Woo-Keun Seo is a biotechnology company focused on developing innovative treatments for vascular diseases. The company is currently in the early stages of clinical development with one drug candidate in Phase 1 trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5nTXNnMFNRTmFuamFLbnlrWGNvT2N4OEVYSE13V1VXWGdSRVNHUThjZVFZcDJ5NjBGNmNwcTN4V3ZZQ0NhRkwwLWVnOFhxbGhpT1RaLTVXbEdUaEFYenJj?oc=5","date":"2021-10-18","type":"trial","source":"Nature","summary":"Interpretable machine learning for early neurological deterioration prediction in atrial fibrillation-related stroke - Nature","headline":"Interpretable machine learning for early neurological deterioration prediction in atrial fibrillation-related stroke","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9DcV9Yc3RjS0d2aGZqMTBDLXg1d1RpVjBjakd1Vl9oVXJrV3pFZkVILVp3c1VEb1ZXQXdLSFdDYlhiQnNJcTBVckRYVHB4dkRKeFRXYUZudUZTMnMxY1pj?oc=5","date":"2021-03-16","type":"pipeline","source":"Nature","summary":"Comorbidity index for predicting mortality at 6 months after reperfusion therapy - Nature","headline":"Comorbidity index for predicting mortality at 6 months after reperfusion therapy","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}